Authors:
AZZOLI CG
SAGAR M
WU A
LOWRY D
HENNINGS H
MORGAN DL
WEINBERG WC
Citation: Cg. Azzoli et al., COOPERATION OF P53 LOSS OF FUNCTION AND V-HA-RAS IN TRANSFORMATION OFMOUSE KERATINOCYTE CELL-LINES, Molecular carcinogenesis, 21(1), 1998, pp. 50-61
Authors:
SAGAR M
SEENSALU R
TYBRING G
DAHL ML
BERTILSSON L
Citation: M. Sagar et al., CYP2C19 GENOTYPE AND PHENOTYPE DETERMINED WITH OMEPRAZOLE IN PATIENTSWITH ACID-RELATED DISORDERS WITH AND WITHOUT HELICOBACTER-PYLORI INFECTION, Scandinavian journal of gastroenterology, 33(10), 1998, pp. 1034-1038
Authors:
SJOSTEDT S
SAGAR M
LINDBERG G
WIKSTROM B
NORD CE
SEENSALU R
Citation: S. Sjostedt et al., PROLONGED AND PROFOUND ACID INHIBITION IS CRUCIAL IN HELICOBACTER-PYLORI TREATMENT WITH A PROTON PUMP INHIBITOR COMBINED WITH AMOXICILLIN, Scandinavian journal of gastroenterology, 33(1), 1998, pp. 39-43
Authors:
SAGAR M
TYBRING G
DAHL ML
BERTILSSON L
SEENSALU R
Citation: M. Sagar et al., THE EFFECT OF OMEPRAZOLE ON INTRAGASTRIC PH AND GASTRIN-LEVELS IS DETERMINED BY THE CYP2C19 POLYMORPHISM MORE THAN BY HELICOBACTER-PYLORI INFECTION IN PATIENTS WITH ACID-RELATED DISEASE, Gastroenterology, 114(4), 1998, pp. 1122-1122
Authors:
SAGAR M
BERTILSSON L
DAHL ML
TYBRING G
SEENSALU R
Citation: M. Sagar et al., INDIVIDUAL METABOLISM OF OMEPRAZOLE IS DETERMINED BY THE GENOTYPE OF THE ENZYME CYP2C19 WITHOUT RELATION TO HELICOBACTER-PYLORI INFECTION, Gastroenterology, 112(4), 1997, pp. 275-275
Authors:
GOLDSCHMIDTCLERMONT PJ
SCHULMAN SP
BRAY PF
CHANDRA NC
GRIGORYEV D
DISE KR
SAGAR M
FOX RJ
COLEMAN LD
RICHARDSON C
DORSEY FC
DUMEE C
KITT MM
OUYANG P
BAUGHMAN KL
GERSTENBLITH G
Citation: Pj. Goldschmidtclermont et al., REFINING THE TREATMENT OF WOMEN WITH UNSTABLE ANGINA - A RANDOMIZED, DOUBLE-BLIND, COMPARATIVE SAFETY AND EFFICACY EVALUATION OF INTEGRELIN(TM) VERSUS ASPIRIN IN THE MANAGEMENT OF UNSTABLE ANGINA, Clinical cardiology, 19(11), 1996, pp. 869-874
Authors:
CHANG M
TYBRING G
DAHL ML
GOTHARSON E
SAGAR M
SEENSALU R
BERTILSSON L
Citation: M. Chang et al., INTERPHENOTYPE DIFFERENCES IN DISPOSITION AND EFFECT ON GASTRIN-LEVELS OF OMEPRAZOLE - SUITABILITY OF OMEPRAZOLE AS A PROBE FOR CYP2C19, British journal of clinical pharmacology, 39(5), 1995, pp. 511-518
Authors:
WEINBERG WC
AZZOLI CG
WU AJ
SAGAR M
MORGAN DL
YUSPA SH
Citation: Wc. Weinberg et al., RECONSTITUTION OF P53-NULL KERATINOCYTE CELL-LINES WITH TEMPERATURE-SENSITIVE P53 - A MODEL FOR EXPLORING THE ROLE OF P53 IN EPIDERMAL BIOLOGY, Journal of investigative dermatology, 104(4), 1995, pp. 599-599
Authors:
SEENSALU R
IWARZON M
JANCZEWSKA I
HAMMARLUND B
OKSANEN A
SAGAR M
Citation: R. Seensalu et al., DOSE-RESPONSE COMPARISON OF LANSOPRAZOLE AND OMEPRAZOLE ON 24-HOUR GASTRIC-ACIDITY AND PLASMA GASTRIN IN HEALTHY-VOLUNTEERS, Gastroenterology, 108(4), 1995, pp. 215-215